-
109
-
83
-
60
-
59
-
45
Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005
Published:
2009-06-03
Articles
-
The scale of the problem
Published: June 3, 2009137PDF: 152 -
Occult cancer and idiopathic venous thromboembolism
Published: June 3, 2009158PDF: 607 -
Tissue factor-bearing microparticles and cancer-associated thrombosis
Published: June 3, 2009198Untitled (): 0 -
Blood-borne tissue factor
Published: June 3, 2009228PDF: 257 -
Tissue factor pathway inhibitor and cancer
Published: June 3, 2009154PDF: 594 -
Tissue factor-PAR2 signaling crosstalk in cancer and angiogenesis
Published: June 3, 2009162PDF: 425 -
Oncogenic events regulating tissue factor expression
Published: June 3, 2009161PDF: 296 -
Hemostatic factors support metastasis by impeding NK cell-mediated elimination of embolic tumor cells
Published: June 3, 2009202PDF: 329 -
The met oncogene drives a genetic program linking cancer to hemostasis
Published: June 3, 2009145PDF: 230 -
Cytokine GRO-a is pivotal in thrombin-induced angiogenesis
Published: June 3, 2009174PDF: 332 -
Low molecular weight heparin and survival in cancer
Published: June 3, 2009160PDF: 166 -
Fibrinolytics, enzyme inhibitors, and cancer survival
Published: June 3, 2009156PDF: 645 -
Vitamin k, warfarin and prothrombin: an alternate pathway to improve cancer survival
Published: June 3, 2009167PDF: 233 -
Future perspective of clinical trials of antithrombotics and cancer survival
Published: June 3, 2009135PDF: 162 -
Clinical trials with angiogenesis inhibitors
Published: June 3, 2009164PDF: 170 -
Vascular complications of endothelium targeting therapies
Published: June 3, 2009150PDF: 158 -
Commentary on thrombotic and bleeding complications of clinical trials of growth factor inhibitors
Published: June 3, 2009133PDF: 689 -
Lymphangiogenesis: a new paradigm for cancer progression and therapy
Published: June 3, 2009126PDF: 149 -
Hemorrhage and thrombosis in acute leukemia
Published: June 3, 2009380PDF: 3591 -
Prevention of disseminated intravascular coagulation in cancer
Published: June 3, 2009383PDF: 1270 -
Bleeding and thrombosis in childhood cancer
Published: June 3, 2009154PDF: 632 -
The protein C system in inflammation and cancer: a critical role for thrombomodulin
Published: June 3, 2009147PDF: 179 -
Heparin effects in metastasis and Trousseau's syndrome: anticoagulation is not the primary mechanism
Published: June 3, 2009295PDF: 196 -
The impact of heparanase on cancer progression
Published: June 3, 2009176PDF: 704 -
Inhibition of tumor growth by heparins in vivo
Published: June 3, 2009133PDF: 173 -
Clinical outcomes in cancer patients with concurrent venous thromboembolism: findings from the RIETE registry
Published: June 3, 2009191PDF: 492 -
Unresolved problems in venous thromboembolism treatment in cancer
Published: June 3, 2009155PDF: 391 -
The role of new antithrombotics
Published: June 3, 2009119PDF: 94 -
Modified Heparins as possible inhibitors of metastasis
Published: June 3, 2009119PDF: 352